149 related articles for article (PubMed ID: 19139372)
1. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.
Bartoccioni E; Scuderi F; Augugliaro A; Chiatamone Ranieri S; Sauchelli D; Alboino P; Marino M; Evoli A
Neurology; 2009 Jan; 72(2):195-7. PubMed ID: 19139372
[No Abstract] [Full Text] [Related]
2. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
3. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.
Hajeer AH; Sawidan FA; Bohlega S; Saleh S; Sutton P; Shubaili A; Tahan AA; Al Jumah M
Int J Immunogenet; 2009 Jun; 36(3):169-72. PubMed ID: 19490212
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
[TBL] [Abstract][Full Text] [Related]
5. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.
Shinomiya N; Nomura Y; Segawa M
Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
[TBL] [Abstract][Full Text] [Related]
7. HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
Hong Y; Li HF; Romi F; Skeie GO; Gilhus NE
Acta Neurol Scand; 2018 Sep; 138(3):219-226. PubMed ID: 29736936
[TBL] [Abstract][Full Text] [Related]
8. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
[TBL] [Abstract][Full Text] [Related]
9. Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases.
Murray EL; Kedar S; Vedanarayanan VV
J Clin Neuromuscul Dis; 2010 Dec; 12(2):76-9. PubMed ID: 21386774
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
Yousefipour GA; Salami Z; Farjadian S
Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
[TBL] [Abstract][Full Text] [Related]
11. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
[TBL] [Abstract][Full Text] [Related]
12. T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients.
Marino M; Maiuri MT; Di Sante G; Scuderi F; La Carpia F; Trakas N; Provenzano C; Zisimopoulou P; Ria F; Tzartos SJ; Evoli A; Bartoccioni E
J Autoimmun; 2014 Aug; 52():113-21. PubMed ID: 24397960
[TBL] [Abstract][Full Text] [Related]
13. [HLA-DQB1 allele polymorphism and clinical characteristics of 15 familial myasthenia gravis cases in north China].
Yang HW; Sun ZL; Zhang MY; Wang SH; Li HF; Cong ZQ; Gao XY; Xie YC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):437-9. PubMed ID: 16883535
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.
Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E
Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460
[TBL] [Abstract][Full Text] [Related]
15. The association between HLA class II haplotype with Graves' disease in Thai population.
Wongsurawat T; Nakkuntod J; Charoenwongse P; Snabboon T; Sridama V; Hirankarn N
Tissue Antigens; 2006 Jan; 67(1):79-83. PubMed ID: 16451208
[TBL] [Abstract][Full Text] [Related]
16. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
Vincent A; Mills K
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
[No Abstract] [Full Text] [Related]
17. No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients.
Sylvia T; Samuel M; Luis G; Zuzet M
Hum Immunol; 2013 Aug; 74(8):983-5. PubMed ID: 23628390
[TBL] [Abstract][Full Text] [Related]
18. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
19. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
